about
The human apoptosis-inducing protein AMID is an oxidoreductase with a modified flavin cofactor and DNA binding activityMutagenicity of DNA adducts derived from ethylene oxide exposure in the pSP189 shuttle vector replicated in human Ad293 cellsImproving the diagnostic accuracy of N-terminal B-type natriuretic peptide in human systolic heart failure by plasma profiling using mass spectrometry.Ultra high-performance liquid chromatography of porphyrins.Ultra high-performance liquid chromatography of porphyrins in clinical materials: column and mobile phase selection and optimisation.Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.Tissue distribution and metabolism of the putative cancer chemopreventive agent 3',4',5'-trimethoxyflavonol (TMFol) in mice.Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma.Liquid chromatography-tandem mass spectrometry of porphyrins and porphyrinogens in biological materials: separation and identification of interfering poly(ethylene) glycol by travelling wave ion mobility spectrometry/tandem mass spectrometry.Improved analysis of vitamin D metabolites in plasma using liquid chromatography tandem mass spectrometry, and its application to cardiovascular research.DNA adducts: mass spectrometry methods and future prospects.Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.Growth hormone for risk stratification and effects of therapy in acute myocardial infarction.The use of turbulent flow chromatography for rapid, on-line analysis of tryptic digests.Trimethylamine N-oxide and prognosis in acute heart failure.Plasma growth hormone is a strong predictor of risk at 1 year in acute heart failure.Separation and fragmentation study of isocoproporphyrin derivatives by UHPLC-ESI-exact mass MS/MS and identification of a new isocoproporphyrin sulfonic acid metabolite.Identification and characterization of (3",4"-dihydroxy)-1,N(2)-benzetheno-2'-deoxyguanosine 3'-monophosphate, a novel DNA adduct formed by benzene metabolites.Proenkephalin and prognosis after acute myocardial infarction.Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.Simultaneous detection of five different 2-hydroxyethyl-DNA adducts formed by ethylene oxide exposure, using a high-performance liquid chromatography/electrospray ionisation tandem mass spectrometry assay.Pro-substance p for evaluation of risk in acute myocardial infarction.Advances in quadrupole and time-of-flight mass spectrometry for peptide MRM based translational research analysis.Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure (from BIOSTAT-CHF)Determination of endogenous and exogenously derived N7-(2-hydroxyethyl)guanine adducts in ethylene oxide-treated ratsPorphyrinogen fragmentation profiles by ultra-high-performance liquid chromatography/electrospray ionisation tandem mass spectrometryTravelling wave ion mobility mass spectrometry of 5-aminolaevulinic acid, porphobilinogen and porphyrinsCurcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivoHigh mass accuracy assay for trimethylamine N-oxide using stable-isotope dilution with liquid chromatography coupled to orthogonal acceleration time of flight mass spectrometry with multiple reaction monitoringIn ReplyTrimethylamine N-oxide and Risk Stratification after Acute Myocardial InfarctionThe measurement of KRAS G12 mutants using multiplexed selected reaction monitoring and ion mobility mass spectrometry
P50
Q24305302-EE18C47F-2E15-416A-8337-F3F0514A0F25Q28246642-CC9C7F83-A072-4C68-959B-2920278441E2Q33290716-FDC0F0B5-9BAC-4095-9CF7-72DB7E5B1C3CQ33952751-E634E469-EAB1-4062-B0F4-8FC97E4B5ED9Q34059458-28C84059-EAC2-40FF-A7AF-ADFF7A8EAB66Q34168543-79B5637D-7EFA-420D-96E5-BD7ABE44B64AQ34210325-4AA4E8FD-A1B9-409C-BAAF-96B06A578258Q34506739-ACEBF59E-7072-464D-88E4-F4ADB2F43F09Q34871810-E3D84455-BA77-4FF2-8D28-366B79E0C2CAQ35174198-57AF14C6-538A-4BF0-880B-1654A4F27A03Q36180140-5B440C4F-32BE-4743-B5BE-75319AB45CEAQ36694528-8A6EBBC8-D564-4403-B425-D61462C1FE67Q40365832-B6A14363-38BF-4E58-AEE8-02784C06F15DQ40431746-6922559C-35E3-4837-8579-AE1B492C96BEQ40914356-754A0A1A-9A35-4052-BE80-9A6E1C6089E0Q41048065-55B278CE-E4D7-46D3-9119-7A2E8A4EE3B5Q43987204-5C87C14C-F0C7-4750-A54B-D86357BD6690Q44107163-61F1D4AA-95C9-4F52-8C19-0A99493B0667Q44538374-65769E76-B902-4381-AEE5-9F2E81888A19Q46610263-31761BF8-DEC8-4884-A49E-B56CB1BFA0DAQ46880054-4703FBC6-9320-41E3-9161-405186358177Q48190165-96725082-BE08-4C87-AE9D-0B3FFAD41BF0Q53094134-CDC636C4-E4B9-4ADD-B3F2-6332572CDC3BQ58102786-B9B5111B-DEDA-4EB6-839B-29756278F279Q79689940-4B37ABE6-1A45-4951-8633-61920AFD0767Q83320320-6E875BA8-28C0-4E50-8DC4-CEA91074D3ABQ83328279-2F9458E4-15F1-42EA-8228-2CB6FD76971AQ85026549-E546B693-AD0C-4FC1-B83E-53AC7F547C2BQ86707194-5A6BC308-6578-4193-964A-ADE58AE17796Q87614068-03FB1DD4-CF14-4AED-AB41-91CDDAC869BFQ89470647-4EB85706-29EF-40E7-B1CC-D71AAD575A4FQ91682599-2B779CD2-0223-4C8D-B0AE-C32856CBC903
P50
description
researcher
@en
wetenschapper
@nl
name
Donald J L Jones
@en
Donald J L Jones
@nl
type
label
Donald J L Jones
@en
Donald J L Jones
@nl
prefLabel
Donald J L Jones
@en
Donald J L Jones
@nl
P106
P31
P496
0000-0001-6583-870X